You keep referring to positive results for Cancell in NCI testing. Please stop assuming that everyone else knows what you're talking about, and cite those results properly in the Cancell article. If you're a natural skeptic, surely you can understand why other editors — myself included – would be interested in actually seeing this data to which you keep referring.
On five-year survival rates, you're quite correct that apparent five-year survival can be improved (without lengthening lifespan) through early detection. I agree that it would be inappropriate to assess efficacy of a drug based on a comparison of five-year survival rates achieved today with five-year survival rates measured ten or twenty years go. That's why clinical trials of any novel treatment regimen always compare the new drug/treatment with the existing 'gold standard' therapy (if any) using patients drawn at the same time from the same population. TenOfAllTrades( talk) 03:19, 20 May 2008 (UTC)
Incidentally, try to remember to log in and sign your talk page comments at all times; you seem to have forgotten to do so in your recent edits to Talk:Cancer Industry. TenOfAllTrades( talk) 04:33, 20 May 2008 (UTC)
You keep referring to positive results for Cancell in NCI testing. Please stop assuming that everyone else knows what you're talking about, and cite those results properly in the Cancell article. If you're a natural skeptic, surely you can understand why other editors — myself included – would be interested in actually seeing this data to which you keep referring.
On five-year survival rates, you're quite correct that apparent five-year survival can be improved (without lengthening lifespan) through early detection. I agree that it would be inappropriate to assess efficacy of a drug based on a comparison of five-year survival rates achieved today with five-year survival rates measured ten or twenty years go. That's why clinical trials of any novel treatment regimen always compare the new drug/treatment with the existing 'gold standard' therapy (if any) using patients drawn at the same time from the same population. TenOfAllTrades( talk) 03:19, 20 May 2008 (UTC)
Incidentally, try to remember to log in and sign your talk page comments at all times; you seem to have forgotten to do so in your recent edits to Talk:Cancer Industry. TenOfAllTrades( talk) 04:33, 20 May 2008 (UTC)